Longevity Startups
430 companies tagged Longevity, with their investors and founders.
Livez is a mobile-first preventive medicine platform that combines AI with clinical protocols and in-house doctors to generate personalized health screening and immunization plans based on a user's data, age, risk factors, and family history. It aligns recommendations with guidelines from health authorities such as the CDC and American Cancer Society to help individuals and families prevent illness before symptoms appear.
3 investors
Animate Biosciences develops peptide therapeutics that target pathological tissue remodeling, using an AI platform trained on multi-omic data from highly regenerative organisms to design novel peptides. The company applies regenerative biology and machine learning to rebuild tissue and organ systems for conditions with limited treatment options.
3 investors
Maximus is an online telehealth clinic offering clinically-validated, personalized prescription protocols and lab testing focused on health optimization ("performance medicine") for men and women, covering areas like testosterone optimization, medical weight loss, hair regrowth, and stress/sleep support. It conducts its own clinical research and develops proprietary formulations, delivering care nationwide without insurance.
3 investors
Mitra develops a non-invasive skin diagnostics platform that combines clinical trials, skin sampling, next-generation sequencing, and data science to guide the design of age-rejuvenating skincare compounds. The company applies genomics to skin health and precision dermatological therapies.
3 investors
Moneta Health provides virtual speech therapy focused on cognitive rehabilitation to treat cognitive impairment and dementia, aiming to improve patients' functional independence and quality of life. It serves patients and healthcare providers as part of post-diagnostic care.
3 investors
NiaHealth offers precision longevity health assessments for Canadians, measuring biomarkers and providing personalized health plans delivered by licensed Nurse Practitioners. Its clinical team combines evidence-based longevity research with coaching to translate test results into actionable recommendations, integrating with members' family doctors where needed.
3 investors
NOVOS is a longevity biotechnology company that develops science-validated supplement formulations and aging assessment tools designed to target the biological mechanisms of aging rather than disease symptoms. The company serves consumers seeking to extend healthspan through evidence-based products backed by clinical trials and mechanistic research.
3 investors
ONTO Health provides personalized fertility, hormone, and longevity care for patients at various stages of reproductive health, combining evidence-based medicine with diagnostics and wellness therapies. The company offers technology-enabled, human-centered care led by reproductive specialists, serving individuals planning fertility, seeking treatment, or exploring preventive reproductive health options.
3 investors
Opt Health connects patients with medical experts for personalized consultations via telemedicine, providing preventive care guidance and treatment plans delivered online and through an integrated pharmacy service.
3 investors
Pelage develops regenerative medicines for hair loss based on stem cell biology, with a lead candidate (PP405) that is a topical small-molecule drug designed to reactivate dormant hair follicle stem cells. It targets conditions including androgenetic alopecia, drug-induced alopecia, and telogen effluvium, and is currently in clinical trials.
3 investors
Permanence Bio is a biotech company developing therapies aimed at cancer prevention by protecting the genome from damage, drawing on aging and DNA repair research. It works to discover cancer-preventing compounds and advance lead compounds from mechanism of action through IND-enabling studies and into the clinic.
3 investors
Photys Therapeutics develops bifunctional small-molecule medicines that use induced proximity to recruit kinases and drive targeted protein phosphorylation, aiming to modulate and repair disease-driving proteins. It is building a therapeutic pipeline for autoimmune, inflammatory, oncology, and cardiometabolic diseases.
3 investors
Prenetics is a health company that operates in genetic testing and precision diagnostics and runs the consumer health supplement brand IM8, sold direct-to-consumer and through Amazon and social commerce channels. The company markets longevity and wellness products globally, including partnerships with athletes and sports organizations.
3 investors
Rehab for JAPAN develops and provides "Rehab Cloud," a SaaS platform for elderly care and rehabilitation providers, along with "Rehab Studio," an online rehabilitation service, and conducts R&D on AI-based care technology. The company serves care facilities and elderly-care operators in Japan.
3 investors
Rejuvenation develops proprietary mRNA and lipid nanoparticle technology to safely lengthen telomeres in human cells, targeting cellular aging and diseases caused by short telomeres including pulmonary fibrosis, liver disease, and bone marrow failure.
3 investors
Replay develops gene therapies for patients with rare genetic diseases. It operates in the biotechnology and gene therapy sector.
3 investors
Savvly offers an SEC-registered investment vehicle designed for extended retirement spans, providing scheduled cash payouts at ages 80, 85, 90, and 95 through a pooled S&P 500 index fund with longevity-focused reallocation. The product serves individuals planning for retirements lasting 25-30 years and their financial advisors.
3 investors
Sironax is a biopharmaceutical company focused on the discovery and development of therapies for neurodegenerative, inflammatory and immunological, metabolic, and rare diseases. Its research targets conditions affecting longevity, those requiring supportive care, and certain rare diseases.
3 investors
Tenpoint Therapeutics develops treatments for age-related ophthalmic conditions, with an initial focus on presbyopia care for the aging eye. The company works with eye care professionals to advance therapies in the ophthalmology market.
3 investors
Total Life provides Medicare-covered telehealth therapy and mental health support for older adults, delivered by licensed therapists via phone or video from home. It also offers group classes for strength, balance, and mindfulness, plus family, couples, and caregiver counseling, with most members covered up to 100% by Medicare and supplemental insurance.
3 investors
Tune Therapeutics develops a therapeutic platform targeting the epigenome to treat complex diseases and regenerative medicine applications. The company works on novel gene network therapies for challenging diseases.
3 investors
Age Well Japan promotes the concept of "Age-Well" β aging positively through challenge and discovery β and works to change the values, culture, and institutions of a super-aged society. The company operates in Japan, focused on services and initiatives for seniors.
3 investors
ReproCELL develops regenerative medicine and cell therapies (including clinical-grade GMP-compliant iPS cells and iPS-derived exosomes) and supplies research reagents, media, genome-editing tools, and cell-processing contract services. It also offers clinical testing (such as HLA testing for organ transplants), mail-in hormone testing, and personal iPS cell creation and storage services for researchers, hospitals, CROs, and individuals.
2 investors
Accuitis is developing a lead drug compound that restores mitochondrial SIRT3 expression to recover healthy cellular function, targeting neurodegenerative diseases including Alzheimer's, Parkinson's, and methamphetamine addiction. Its work is in preclinical research and development.
2 investors